Baeyer-Villiger oxidation of bridged endo-tricyclic ketones with engineered Escherichia coli expressing monooxygenases of bacterial origin

Synlett

Volumn , Issue 18, 2005, Pages 2751-2754

  Mihovilovic, Marko D ^a   Snajdrova, Radka ^a   Winninger, Alexander ^a   Rudroff, Florian ^a  

^a VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

Baeyer Villiger oxidation; Biocatalysis; Biooxidation; Monooxygenase; Recombinant whole cell biotransformation; Stereoselectivity

Indexed keywords

BRIDGED COMPOUND; CYCLOHEXANONE DERIVATIVE; CYCLOPENTANONE DERIVATIVE; KETONE DERIVATIVE; LACTONE; UNSPECIFIC MONOOXYGENASE;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL STRAIN; BAEYER VILLIGER REACTION; BIOTRANSFORMATION; CATALYSIS; CONTROLLED STUDY; ENZYME SUBSTRATE; ESCHERICHIA COLI; GENE CLUSTER; GENE LIBRARY; NONHUMAN; OXIDATION; PROTEIN ENGINEERING; PROTEIN EXPRESSION; STEREOSPECIFICITY; SYNTHESIS; WHOLE CELL;

EID: 27844558328     PISSN: 09365214     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-918938     Document Type: Article

References (43)

1. (a) Mihovilovic, M. D.; Rudroff, F.; Grötzl, B. Curr. Org. Chem. 2004, 8, 1057.
2. (b) Brink, G.-J.; Arends, I. W. C. E.; Sheldon, R. A. Chem. Rev. 2004, 104, 4105.
3. (a) Bolm, C. In Peroxide Chemistry; Adam, W., Ed.; Wiley-VCH: Weinheim, 2000, 494-510.
4. (b) Strukul, G. Angew. Chem. Int. Ed. 1998, 37, 1198.
5. (a) Kamerbeek, N. M.; Janssen, D. B.; van Berkel, W. J. H.; Fraaije, M. W. Adv. Synth. Catal. 2003, 345, 667.
6. (b) Mihovilovic, M. D.; Müller, B.; Stanetty, P. Eur. J. Org. Chem. 2002, 3711.
7. (c) Stewart, J. D. Curr. Org. Chem. 1998, 2, 195.
8. (d) Roberts, S. M.; Wan, P. W. H. J. Mol. Catal. B: Enzym. 1998, 4, 111.
9. (e) Willetts, A. Trends Biotechnol. 1997, 15, 55.
10. (f) Walsh, C. T.; Chen, Y.-C. J. Angew. Chem. 1988, 100, 342.
11. Mihovilovic, M. D.; Rudroff, F.; Grötzl, B.; Kapitan, P.; Snajdrova, R.; Rydz, J.; Mach, R. Angew. Chem. Int. Ed. 2005, 44, 3609.
12. For another evaluation of some BVMOs of this library see: Kyte, B. G.; Rouviere, P.; Cheng, Q.; Stewart, J. D. J. Org. Chem. 2004, 69, 12.
13. (a) Mihovilovic, M. D.; Rudroff, F.; Müller, B.; Stanetty, P. Bioorg. Med. Chem. Lett. 2003, 13, 1479.
14. (b) Wang, S.; Kayser, M. M.; Iwaki, H.; Lau, P. C. K. J. Mol. Catal. B. Enzym. 2003, 22, 211.
15. (c) Mihovilovic, M. D.; Müller, B.; Kayser, M. M.; Stanetty, P. Synlett 2002, 700.
16. (a) Mihovilovic, M. D.; Kapitan, P. Tetrahedron Lett. 2004, 45, 2751.
17. (b) Kelly, D. R.; Knowles, C. J.; Mahdi, J. G.; Taylor, I. N.; Wright, M. A. J. Chem. Soc., Chem. Commun. 1995, 729.
18. (c) Alphand, V.; Furstoss, R. J. Org. Chem. 1992, 57, 1306.
19. Stewart, J. D. Curr. Opin. Biotechnol. 2000, 363.
20. Van Beilen, J. B.; Duetz, W. A.; Schmid, A.; Witholt, B. Trends Biotechnol. 2003, 27, 170.
21. For a S. cerevisiae based whole-cell expression system of BVMOs see: Kayser, M.; Chen, G.; Stewart, J. Synlett 1999, 153; and references therein.
22. For an excellent review in biocatalytic desymmetrization reactions see: Garcia-Urdiales, E.; Alfonso, I.; Gotor, V. Chem. Rev. 2005, 105, 313.
23. Gassman, P. G.; Marshall, J. L. Org. Synth. 1968, 48, 68.
24. Setzer, W. N.; Whitaker, K. W.; Thompson, M. A.; Yang, X.-J.; Brown, M. L. J. Org. Chem. 1992, 57, 2812.
25. Fujita, E.; Inoue, T.; Nagao, Y. Tetrahedron 1984, 40, 1215.
26. (a) Taschner, M. J.; Peddada, L. J. Chem. Soc., Chem. Commun. 1992, 1384.
27. (b) Taschner, M. J.; Black, D. J. J. Am. Chem. Soc. 1988, 110, 6892.
28. Donoghue, N. A.; Norris, D. B.; Trudgill, P. W. Eur. J. Biochem. 1976, 63, 175.
29. Brzostowicz, P.; Walters, D. M.; Thomas, S. M.; Nagarajan, V.; Rouviere, P. E. Appl. Environ. Microbiol. 2003, 69, 334.
30. Bramucci, M. G.; Brzostowicz, P. C.; Kostichka, K. N.; Nagarajan, V.; Rouviere, P. E.; Thomas, S. M. PCT Int. Appl., WO 2003020890, 2003; Chem. Abstr. 2003, 138, 233997.
31. Brzostowicz, P. C.; Gibson, K. L.; Thomas, S. M.; Blasko, M. S.; Rouviere, P. E. J. Bacteriol. 2000, 182, 4241.
32. Griffin, M.; Trudgill, P. W. Eur. J. Biochem. 1976, 63, 199.
33. 3): δ = 22.1 (t), 38.6 (d), 39.3 (t), 40.6 (t), 41.3 (d), 221.0 (s).
34. (a) Mihovilovic, M. D.; Rudroff, F.; Grötzl, B.; Stanetty, P. Eur. J. Org. Chem. 2005, 809.
35. (b) Mihovilovic, M. D.; Müller, B.; Schulze, A.; Stanetty, P.; Kayser, M. M. Eur. J. Org. Chem. 2003, 2243.
36. Typical Procedure for Screening Experiment in Multi-Well Dishes (12 or 24 Wells). Each well was charged with LB-amp medium (2 mL/12-well format or 1 mL/24-well format) and inoculated with 1% of an overnight preculture of recombinant E. coli strains. A plate was incubated at 120 rpm at 37 °C on an orbital shaker for 2 h. IPTG was added (final concentration of 0.025 mM) together with substrate (1 mg or 0.5 mg) and β-cyclodextrin (1 equiv). The plate was shaken at r.t. for 24 h and then analyzed by chiral phase GC after extraction of the sample with EtOAc.
37. (a) Doig, S. D.; Pickering, S. C. R.; Lye, G. J.; Woodley, J. M. Biotechnol. Bioeng. 2002, 42.
38. (b) Lye, G. J.; Dalby, P. A.; Woodley, J. M. Org. Process Res. Dev. 2002, 6, 434.
39. 3); 95% ee.
40. Yamamoto, H.; Katsube, J.; Sugie, A.; Shimomura, H. Tetrahedron Lett. 1976, 45, 4099.
41. Reetz, M. T.; Brunner, B.; Schneider, T.; Schulz, F.; Clouthier, C. M.; Kayser, M. M. Angew. Chem. Int. Ed. 2004, 43, 4078.
42. Bocola, M.; Schulz, F.; Leca, F.; Vogel, A.; Fraaije, M. W.; Reetz, M. T. Adv. Synth. Catal. 2005, 347, 979.
43. Malito, E.; Alfieri, A.; Fraaije, M. W.; Mattevi, A. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 13157.